Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Revenue (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Revenue for 12 consecutive years, with $38.2 million as the latest value for Q1 2026.

  • For Q1 2026, Revenue rose 316.85% year-over-year to $38.2 million; the TTM value through Mar 2026 reached $46.9 million, down 79.44%, while the annual FY2025 figure was $42.7 million, 60.55% down from the prior year.
  • Revenue hit $38.2 million in Q1 2026 for Wave Life Sciences, up from $8.7 million in the prior quarter.
  • Across five years, Revenue topped out at $199.5 million in Q4 2024 and bottomed at $285000.0 in Q3 2022.
  • Average Revenue over 5 years is $41.7 million, with a median of $16.3 million recorded in 2023.
  • Year-over-year, Revenue crashed 99.22% in 2022 and then soared 17168.07% in 2023.
  • Wave Life Sciences' Revenue stood at $81.2 million in 2022, then soared by 57.88% to $128.2 million in 2023, then surged by 55.62% to $199.5 million in 2024, then tumbled by 95.64% to $8.7 million in 2025, then surged by 339.66% to $38.2 million in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $38.2 million, $8.7 million, and $9.2 million for Q1 2026, Q2 2025, and Q1 2025 respectively.